Cardiac Drugs in Pregnancy

  • Karen Sliwa
  • John Anthony

Part of the Current Cardiovascular Therapy book series (CCT)

Table of contents

  1. Front Matter
    Pages i-xii
  2. John Anthony
    Pages 1-9
  3. Eckhart J. Buchmann
    Pages 11-34
  4. Karen Sliwa, Kemilembe B. Tibazarwa
    Pages 35-52
  5. Annemien E. van den Bosch, Titia P. E. Ruys, Jolien W. Roos-Hesselink
    Pages 53-77
  6. Vera Regitz-Zagrosek, Christa Gohlke-Baerwolf, Bernard Iung, Petronella G. Pieper
    Pages 79-105
  7. Back Matter
    Pages 123-131

About this book


In the western world, the risk of cardiovascular disease in pregnancy has grown due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading to early diabetes and hypertension. As a result more women are requiring drug therapy during pregnancy  and some data has shown an altered pharmacodynamic profile in pregnant women when compared to the non-pregnant population.

Cardiac Drugs in Pregnancy presents up-to-date research for the treatment of cardiovascular disease during pregnancy, and  discusses the most important indications of drug usage in pregnancy and postpartum. The book aims to assess the potential risk of drugs and their possible benefit against each other, making it an essential read for a wide range of health professionals involved in cardiac drug therapy in pregnancy.


Anticoagulation Maternal heart disease Postpartum heart disease

Editors and affiliations

  • Karen Sliwa
    • 1
  • John Anthony
    • 2
  1. 1.Hatter Institute for Cardiovascular ResearchCape TownSouth Africa
  2. 2.Department of Obstetrics & GynaecologyGroote Schuur HospitalCape TownSouth Africa

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag London 2014
  • Publisher Name Springer, London
  • eBook Packages Medicine Medicine (R0)
  • Print ISBN 978-1-4471-5471-6
  • Online ISBN 978-1-4471-5472-3
  • Buy this book on publisher's site